82 related articles for article (PubMed ID: 9473819)
1. Exogenous surfactant therapy for neonatal respiratory distress syndrome: a two-year clinical experience.
Wu CH; Kua KE
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(6):463-7. PubMed ID: 9473819
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of surfactant replacement therapy for preterm infants with respiratory distress syndrome.
Lim WL; Lim CT; Chye JK
Med J Malaysia; 1998 Dec; 53(4):376-84. PubMed ID: 10971981
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
5. Exogenous surfactant for treatment of respiratory distress syndrome in premature infants.
Chen JY
J Formos Med Assoc; 1990 Feb; 89(2):110-4. PubMed ID: 1973717
[TBL] [Abstract][Full Text] [Related]
6. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
Sehgal SS; Ewing CK; Richards T; Taeusch HW
J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
[TBL] [Abstract][Full Text] [Related]
7. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
8. [Effects of surfactant administration in premature infants with severe respiratory distress syndrome].
Morón A; Luaces J; Esteban JC; Medina D; Sánchez JM; Manzano JL
Med Clin (Barc); 1996 Jun; 107(5):165-8. PubMed ID: 8758674
[TBL] [Abstract][Full Text] [Related]
9. Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?
Tsakalidis C; Giougki E; Karagianni P; Dokos C; Rallis D; Nikolaidis N
Turk J Pediatr; 2012; 54(4):368-75. PubMed ID: 23692717
[TBL] [Abstract][Full Text] [Related]
10. Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome.
Speer CP; Gefeller O; Groneck P; Laufkötter E; Roll C; Hanssler L; Harms K; Herting E; Boenisch H; Windeler J
Arch Dis Child Fetal Neonatal Ed; 1995 Jan; 72(1):F8-13. PubMed ID: 7743295
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV
J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532
[TBL] [Abstract][Full Text] [Related]
12. Short-term outcome of pulmonary hemorrhage in very-low-birth-weight preterm infants.
Yen TA; Wang CC; Hsieh WS; Chou HC; Chen CY; Tsao PN
Pediatr Neonatol; 2013 Oct; 54(5):330-4. PubMed ID: 23711674
[TBL] [Abstract][Full Text] [Related]
13. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
Ghaemi S; Mohamadymasodi M; Kelishadi R
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
[TBL] [Abstract][Full Text] [Related]
15. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment.
Dunn MS; Shennan AT; Zayack D; Possmayer F
Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278
[TBL] [Abstract][Full Text] [Related]
16. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial comparing two natural surfactants (Survanta vs. bLES) for treatment of neonatal respiratory distress syndrome.
Lam BC; Ng YK; Wong KY
Pediatr Pulmonol; 2005 Jan; 39(1):64-9. PubMed ID: 15558604
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and outcomes of respiratory distress syndrome in term and late-preterm neonates].
Chen A; Shi LP; Zheng JY; Du LZ
Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):654-7. PubMed ID: 19099850
[TBL] [Abstract][Full Text] [Related]
19. Synthetic surfactant for rescue treatment of respiratory distress syndrome in premature infants weighing from 700 to 1350 grams: impact on hospital resource use and charges.
Mauskopf JA; Backhouse ME; Jones D; Wold DE; Mammel MC; Mullett M; Guthrie R; Long WA
J Pediatr; 1995 Jan; 126(1):94-101. PubMed ID: 7815233
[TBL] [Abstract][Full Text] [Related]
20. Surfactant therapy in respiratory distress syndrome--the first local experience.
Lim NL; Nordin MM; Cheah IG
Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
